CLINICAL_TRIALS
trial_result
· 2024-04-12
Clinical Trial Update: VAC071: A Study to Assess Efficacy of the ChAd63/MVA PvDBP Vaccines [Phase 2]
Summary
Phase 2 trial investigating the ChAd63/MVA PvDBP vaccines for Plasmodium vivax malaria has completed with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Oxford | Conditions: Malaria, Vivax | Phase 2 | Status: COMPLETED | Results posted: 2024-04-12